(Q35994852)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

acute promyelocytic leukemia

6 January 2020

main subject

arsenic trioxide

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sixten Körper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Hubert Schrezenmeier

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

2387-2401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Arsenic-induced apoptosis in malignant cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Sodium arsenite enhances AP-1 and NFkappaB DNA binding and induces stress protein expression in precision-cut rat lung slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Establishment and characterization of an arsenic-sensitive monoblastic leukaemia cell line (SigM5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts -- a possible mechanism for arsenite's comutagenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Opposite effect of NF-kB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Clinical activity of arsenic trioxide for the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Heavy metal poisoning and its laboratory investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190412331272686

10.1080/10428190412331272686

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621751%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference